Leveraging Synthetic Biology’s Promise and Managing Potential Risk
As more applications based on synthetic biology come to market, are the existing federal regulations adequate to address the risks posed by this emerging technology?
Please join us for the release of our new report, The DNA of the U.S. Regulatory System: Are We Getting It Right for Synthetic Biology? Panelists will discuss how synthetic biology applications would be regulated by the U.S. Coordinated Framework for Regulation of Biotechnology, how this would affect the market pathway of these applications and whether the existing framework will protect human health and the environment.
A light lunch will be served.
Check back here for the full list of panelists.
Science and Technology Innovation Program
The Science and Technology Innovation Program (STIP) serves as the bridge between technologists, policymakers, industry, and global stakeholders. Read more
Thank you for your interest in this event. Please send any feedback or questions to our Events staff.